P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)

Bibliographic Details
Main Authors: J. N. Nørgaard, N. Abildgaard, A. Lysén, G. Tsykunova, A. J. Vangsted, C. Joao, N. Remen, L. Osnes, J. P. Connelly, M.-E. R. Revheim, F. Schjesvold
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000846620.98940.79
_version_ 1827336340289617920
author J. N. Nørgaard
N. Abildgaard
A. Lysén
G. Tsykunova
A. J. Vangsted
C. Joao
N. Remen
L. Osnes
J. P. Connelly
M.-E. R. Revheim
F. Schjesvold
author_facet J. N. Nørgaard
N. Abildgaard
A. Lysén
G. Tsykunova
A. J. Vangsted
C. Joao
N. Remen
L. Osnes
J. P. Connelly
M.-E. R. Revheim
F. Schjesvold
author_sort J. N. Nørgaard
collection DOAJ
first_indexed 2024-03-07T18:30:01Z
format Article
id doaj.art-754b70b413ea4335b56f9be28bc726ef
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:30:01Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-754b70b413ea4335b56f9be28bc726ef2024-03-02T06:40:49ZengWileyHemaSphere2572-92412022-06-01682882910.1097/01.HS9.0000846620.98940.79202206003-00828P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)J. N. Nørgaard0N. Abildgaard1A. Lysén2G. Tsykunova3A. J. Vangsted4C. Joao5N. Remen6L. Osnes7J. P. Connelly8M.-E. R. Revheim9F. Schjesvold101 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital4 Department of Hematology, Odense University Hospital1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital6 Division of Hematology, Haukeland University Hostpital, Bergen, Norway7 Departmen of Hematology, Rigshospitalet, Copenhagen, Denmark8 Department of Hematology, Champalimaud Centre for the Unknown, Lisboa, Portugal1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital9 Department of Immunology10 Division for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway2 Institute of Clinical Medicine1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospitalhttp://journals.lww.com/10.1097/01.HS9.0000846620.98940.79
spellingShingle J. N. Nørgaard
N. Abildgaard
A. Lysén
G. Tsykunova
A. J. Vangsted
C. Joao
N. Remen
L. Osnes
J. P. Connelly
M.-E. R. Revheim
F. Schjesvold
P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
HemaSphere
title P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_full P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_fullStr P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_full_unstemmed P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_short P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
title_sort p938 carfilzomib lenalidomide dexamethasone consolidation in myeloma patients with a positive fdg pet ct after upfront autologous stem cell transplantation a phase ii study conpet
url http://journals.lww.com/10.1097/01.HS9.0000846620.98940.79
work_keys_str_mv AT jnnørgaard p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT nabildgaard p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT alysen p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT gtsykunova p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT ajvangsted p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT cjoao p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT nremen p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT losnes p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT jpconnelly p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT merrevheim p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet
AT fschjesvold p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet